Targeted therapy in prostate cancer: is there hope beyond the androgen receptor?

Oncology (Williston Park). 2013 Jul;27(7):628, 630, 637-8.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Drug Resistance, Neoplasm / drug effects*
  • Humans
  • Male
  • Molecular Targeted Therapy / trends*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents